Terms: = Leukemia AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
299 results:
1. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML.
Lo Presti V; Meringa A; Dunnebach E; van Velzen A; Moreira AV; Stam RW; Kotecha RS; Krippner-Heidenreich A; Heidenreich OT; Plantinga M; Cornel A; Sebestyen Z; Kuball J; van Til NP; Nierkens S
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580329
[TBL] [Abstract] [Full Text] [Related]
2. Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic review.
Motallebzadeh Khanmiri J; Alizadeh M; Esmaeili S; Gholami Z; Safarzadeh A; Khani-Eshratabadi M; Baghbanzadeh A; Alizadeh N; Baradaran B
Cytotherapy; 2024 May; 26(5):427-435. PubMed ID: 38483358
[TBL] [Abstract] [Full Text] [Related]
3. NKT-Licensed In Vivo Dendritic Cell-Based Immunotherapy as Cellular Immunodrugs for Cancer treatment.
Fujii SI; Shimizu K
Crit Rev Oncog; 2024; 29(1):45-61. PubMed ID: 38421713
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic impact of peripheral blood wt1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy.
Sato H; Kobayashi T; Kameoka Y; Teshima K; Watanabe A; Yamada M; Yamashita T; Noguchi S; Michisita Y; Fujishima N; Kuroki J; Takahashi N
Int J Clin Oncol; 2024 Apr; 29(4):481-492. PubMed ID: 38334897
[TBL] [Abstract] [Full Text] [Related]
5. A new genomic framework to categorize pediatric acute myeloid leukemia.
Umeda M; Ma J; Westover T; Ni Y; Song G; Maciaszek JL; Rusch M; Rahbarinia D; Foy S; Huang BJ; Walsh MP; Kumar P; Liu Y; Yang W; Fan Y; Wu G; Baker SD; Ma X; Wang L; Alonzo TA; Rubnitz JE; Pounds S; Klco JM
Nat Genet; 2024 Feb; 56(2):281-293. PubMed ID: 38212634
[TBL] [Abstract] [Full Text] [Related]
6.
Choi YJ; Min YK; Lee ST; Choi JR; Shin S
Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
[TBL] [Abstract] [Full Text] [Related]
7. A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML.
Dao T; Xiong G; Mun SS; Meyerberg J; Korontsvit T; Xiang J; Cui Z; Chang AY; Jarvis C; Cai W; Luo H; Pierson A; Daniyan A; Yoo S; Takao S; Kharas M; Kentsis A; Liu C; Scheinberg DA
Blood; 2024 Feb; 143(6):507-521. PubMed ID: 38048594
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of wt1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia.
Yu T; Zhan Q; Yan X; Luo X; Wang X; Tang X; Zhang H; Yang Z; Chen J; Liu L; Wang L
Cancer Biol Ther; 2023 Dec; 24(1):2285801. PubMed ID: 38031921
[TBL] [Abstract] [Full Text] [Related]
9. Genomic Mutation Profiles of Patients with Acute Myeloid leukemia in Korea: a Single-Center Experience.
Han E; Ryu S; Kim D; Koh EH; Byun JH; Lee DH
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948498
[TBL] [Abstract] [Full Text] [Related]
10. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
[TBL] [Abstract] [Full Text] [Related]
11. Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.
Hu C; Fu X; Li S; Chen C; Zhao X; Peng J
Daru; 2024 Jun; 32(1):11-24. PubMed ID: 37926762
[TBL] [Abstract] [Full Text] [Related]
12. [leukemia Genotype Analysis of Children with Acute Lymphoblastic leukemia in Yunnan Area].
Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
[TBL] [Abstract] [Full Text] [Related]
13. wt1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.
Fløisand Y; Remberger M; Bigalke I; Josefsen D; Vålerhaugen H; Inderberg EM; Olaussen RW; Gjertsen BT; Goedkoop R; Geiger C; Prinz PU; Schnorfeil FM; Pinkernell K; Schendel DJ; Kvalheim G
Leukemia; 2023 Sep; 37(9):1842-1849. PubMed ID: 37507426
[TBL] [Abstract] [Full Text] [Related]
14. A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis.
Morris VS; Ghazi H; Fletcher DM; Guinn BA
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298623
[TBL] [Abstract] [Full Text] [Related]
15. Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs.
Fujiki F; Morimoto S; Nishida Y; Tanii S; Aoyama N; Inatome M; Inoue K; Katsuhara A; Nakajima H; Nakata J; Nishida S; Tsuboi A; Oka Y; Oji Y; Sogo S; Sugiyama H
Cancer Immunol Immunother; 2023 Jul; 72(7):2347-2356. PubMed ID: 36939853
[TBL] [Abstract] [Full Text] [Related]
16. Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.
Hosono N; Chi S; Yamauchi T; Fukushima K; Shibayama H; Katagiri S; Gotoh A; Eguchi M; Morishita T; Ogasawara R; Kondo T; Yanada M; Yamamoto K; Kobayashi T; Kuroda J; Usuki K; Utsu Y; Yoshimitsu M; Ishitsuka K; Ono T; Takahashi N; Iyama S; Kojima K; Nakamura Y; Fukuhara S; Izutsu K; Abutani H; Yamauchi N; Yuda J; Minami Y;
Cancer Sci; 2023 May; 114(5):2098-2108. PubMed ID: 36793248
[TBL] [Abstract] [Full Text] [Related]
17. [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease].
Su L; Tan YH; Lin H; Han W; Yang YP; Liu XL; Sun JN; Liu QJ; Gao SJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1021-1027. PubMed ID: 36709108
[No Abstract] [Full Text] [Related]
18. Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia.
Ye MT; Wang Y; Zuo Z; Calin S; He H; Tang Z; Jabbour EJ; Borthakur G; Zhang Y; Yang Y; You MJ
Cancer; 2023 Jan; 129(1):49-59. PubMed ID: 36281717
[TBL] [Abstract] [Full Text] [Related]
19. Genomic alterations in a cohort of pediatric acute myeloid leukemia patients at two cancer centers in Colombia.
Yunis LK; Linares-Ballesteros A; Barros G; Garcia J; Aponte N; Niño L; Uribe G; Quintero E; Perez J; Martinez L; Yunis JJ
Int J Hematol; 2023 Feb; 117(2):269-277. PubMed ID: 36279042
[TBL] [Abstract] [Full Text] [Related]
20. Transformation from polycythemia vera to acute promyelocytic leukemia: Case report and literature review.
Li WW; Sui XF; Fan S; Xu H; Wang CL; Wang FY; Mo XD
Medicine (Baltimore); 2022 Aug; 101(32):e30064. PubMed ID: 35960050
[TBL] [Abstract] [Full Text] [Related]
[Next]
